The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Exelixis Announces Webcast of January 9 Presentation at the J.P. Morgan 31st Annual Healthcare Conference

Thursday, December 13, 2012

Exelixis Announces Webcast of January 9 Presentation at the J.P. Morgan 31st Annual Healthcare Conference16:15 EST Thursday, December 13, 2012 SOUTH SAN FRANCISCO, Calif. (Business Wire) -- Exelixis, Inc. (NASDAQ: EXEL) today announced that Michael M. Morrissey, Ph.D., the company's president and chief executive officer, will present at the J.P. Morgan 31st Annual Healthcare Conference at 5:00 p.m. EST / 2:00 p.m. PST on Wednesday, January 9, 2013, in San Francisco. During the presentation, Dr. Morrissey will review the company's development plans and priorities for cabozantinib in 2013. He will also discuss the company's corporate strategy and financial outlook, and provide a general business update. The presentation will be webcast and may be accessed via the Event Calendar page under Investors & Media at www.exelixis.com. About Exelixis Exelixis, Inc. is a biotechnology company committed to developing small molecule therapies for the treatment of cancer. Exelixis is focusing its proprietary resources and development efforts exclusively on COMETRIQ™ (cabozantinib). Exelixis has also established a portfolio of other novel compounds that it believes have the potential to address serious unmet medical needs, many of which are being advanced by partners as part of collaborations. For more information, please visit the company's web site at www.exelixis.com. Exelixis, Inc.Charles Butler, 650-837-7277Vice President,Investor Relations andCorporate Communicationscbutler@exelixis.com